Atherosclerotic renal artery stenosis in the post-CORAL era part 2: new directions in Transcatheter Nephron Salvage following flawed revascularization trials.

[1]  G. Bakris,et al.  The double challenge of resistant hypertension and chronic kidney disease , 2015, The Lancet.

[2]  A. Frigo,et al.  Treatment of atherosclerotic renovascular hypertension: review of observational studies and a meta-analysis of randomized clinical trials. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  L. Lerman,et al.  Mitochondria: A Pathogenic Paradigm in Hypertensive Renal Disease , 2015, Hypertension.

[4]  L. Lerman,et al.  Intra-renal delivery of mesenchymal stem cells attenuates myocardial injury after reversal of hypertension in porcine renovascular disease , 2015, Stem Cell Research & Therapy.

[5]  P. D. de Leeuw,et al.  European consensus on the diagnosis and management of fibromuscular dysplasia. , 2014, Journal of hypertension.

[6]  T. Sos,et al.  Did renal artery stent placement fail in the Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study or did the CORAL Study Fail Renal Artery Stent Placement? The CORAL roll-in experience and the CORAL trials. , 2014, Journal of vascular and interventional radiology : JVIR.

[7]  L. Lerman,et al.  Predictive role of renal resistive index for clinical outcome after revascularization in hypertensive patients with atherosclerotic renal artery stenosis: a monocentric observational study , 2014, Cardiovascular Ultrasound.

[8]  R. Rapanà,et al.  When stenting in renal artery stenosis? Update on pathophysiology of ischemic nephropathy and management strategies , 2013 .

[9]  N. Câmara,et al.  Mesenchymal Stem Cells (MSC) Prevented the Progression of Renovascular Hypertension, Improved Renal Function and Architecture , 2013, PloS one.

[10]  T. Hinds,et al.  Peroxisome Proliferator-Activated Receptor δ Agonist, HPP593, Prevents Renal Necrosis under Chronic Ischemia , 2013, PloS one.

[11]  L. Lerman,et al.  A Mitochondrial Permeability Transition Pore Inhibitor Improves Renal Outcomes After Revascularization in Experimental Atherosclerotic Renal Artery Stenosis , 2012, Hypertension.

[12]  E. Tuzcu,et al.  Predictive value of renal resistive index in percutaneous renal interventions for atherosclerotic renal artery stenosis. , 2012, The Journal of invasive cardiology.

[13]  A. Morganti,et al.  The Medical and Endovascular Treatment of Atherosclerotic Renal Artery Stenosis (METRAS) study: rationale and study design , 2012, Journal of Human Hypertension.

[14]  T. Zeller,et al.  RADAR – A randomised, multi-centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis , 2009, Trials.

[15]  A. Leonard,et al.  Prediction of hypertension improvement after stenting of renal artery stenosis: comparative accuracy of translesional pressure gradients, intravascular ultrasound, and angiography. , 2009, Journal of the American College of Cardiology.

[16]  S. Textor,et al.  Preliminary study of the use of drug-eluting stents in atherosclerotic renal artery stenoses 4 mm in diameter or smaller. , 2008, Journal of vascular and interventional radiology : JVIR.

[17]  F. Neumann,et al.  Treatment of instent restenosis following stent‐supported renal artery angioplasty , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[18]  Ganesh Manoharan,et al.  Assessment of renal artery stenosis severity by pressure gradient measurements. , 2006, Journal of the American College of Cardiology.

[19]  Rodney A. White,et al.  ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography , 2006, Circulation.

[20]  C. Nicolau,et al.  Value of Doppler Sonography for Predicting Clinical Outcome After Renal Artery Revascularization in Atherosclerotic Renal Artery Stenosis , 2005, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[21]  Rajiv Sawhney,et al.  Atheroemboli during renal artery angioplasty: an ex vivo study. , 2005, Journal of vascular surgery.

[22]  K. Chopra,et al.  Cyclosporine protects against ischemia/reperfusion injury in rat kidneys. , 2005, Toxicology.

[23]  F. Neumann,et al.  Stent angioplasty of severe atherosclerotic ostial renal artery stenosis in patients with diabetes mellitus and nephrosclerosis , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[24]  R. Bigazzi,et al.  A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  K. Rocha-Singh,et al.  Long‐term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[26]  P. Serruys,et al.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. , 2002, The New England journal of medicine.

[27]  G. Chatellier,et al.  Proteinuria in renal artery occlusion is related to active renin concentration and contralateral kidney size , 2002, Journal of hypertension.

[28]  A. Novick.  Renovascular disease in diabetes mellitus: treatment by percutaneous transluminal renal angioplasty. , 1999, The Journal of urology.

[29]  W. Mali,et al.  Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial , 1999, The Lancet.

[30]  G. Cook,et al.  Individual kidney function in atherosclerotic nephropathy. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[31]  J. Mehlsen,et al.  The pulsatility index and the resistive index in renal arteries. Associations with long-term progression in chronic renal failure. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[32]  W. Mali,et al.  Atherosclerotic renal artery stenosis: ostial or truncal? , 1996, Radiology.

[33]  R. Colvin,et al.  Preliminary description of focal segmental glomerulosclerosis in patients with renovascular disease , 1996, The Lancet.

[34]  J. Halimi,et al.  Albuminuria predicts renal functional outcome after intervention in atheromatous renovascular disease , 1995, Journal of hypertension.

[35]  R. Xavier,et al.  Atheroembolic Renal Failure after Invasive Procedures: Natural History Based on 52 Histologically Proven Cases , 1995, Medicine.

[36]  C. Bredenberg,et al.  Should percutaneous transluminal renal artery angioplasty be applied to ostial renal artery atherosclerosis? , 1995, Journal of vascular surgery.

[37]  A. Amery,et al.  Percutaneous transluminal renal angioplasty: Initial results and long-term follow-up in 202 patients , 1990, CardioVascular and Interventional Radiology.

[38]  J. Staessen,et al.  Short-term morphologic results of percutaneous transluminal renal angioplasty as determined with angiography. , 1989, Radiology.

[39]  N. Madias,et al.  Percutaneous Transluminal Renal Angioplasty in Management of Atherosclerotic Renovascular Hypertension: Results in 100 Patients , 1989, Hypertension.

[40]  H. Jacobson,et al.  Ischemic renal disease: an overlooked clinical entity? , 1988, Kidney international.

[41]  P. Sones,et al.  Percutaneous angioplasty in clinical management of renovascular hypertension: initial and long-term results. , 1985, Radiology.

[42]  J. Laragh,et al.  Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. , 1983, The New England journal of medicine.

[43]  E. Ring,et al.  Renal Artery Stenosis: Anatomic Classification for Percutaneous Transluminal Angioplasty , 1982 .

[44]  G. Moneta.  Embolic Protection and Platelet Inhibition During Renal Artery Stenting , 2009 .

[45]  C. Zoccali,et al.  Stenting of renal artery stenosis in coronary artery disease (RAS-CAD) study: a prospective, randomized trial. , 2009, Journal of nephrology.

[46]  G. Chatellier,et al.  Restenosis after a first percutaneous transluminal renal angioplasty. , 1993, Hypertension.